Medicare Enrolled
Dr. Richard Buck, M.D.
Hematology · Sarasota, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Buck from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Buck?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Buck
Dr. Richard Buck is a hematology specialist in Sarasota, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Buck performed 198,388 Medicare services across 3,784 unique beneficiaries.
Between the years covered by Open Payments, Dr. Buck received a total of $2,339 from 47 pharmaceutical and/or device companies across 109 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Buck is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 21% volume in FL
$2,339 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 75497 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗198,388
Medicare services
Top 21% in FL for hematology
3,784
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,919 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
94,350 | $0 | $4 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
22,850 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 18,850 | $1 | $5 |
| Pembrolizumab injection (Keytruda) | 14,200 | $43 | $137 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
12,100 | $36 | $108 |
| Denosumab injection (Prolia/Xgeva) | 10,740 | $18 | $51 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,014 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
3,350 | $8 | $29 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
3,140 | $64 | $232 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
3,038 | $8 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,064 | $95 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,800 | $1 | $28 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,076 | $11 | $69 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
1,059 | $2 | $7 |
| Anti-nausea injection (ondansetron/Zofran) | 688 | $0 | $9 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
632 | $22 | $84 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
607 | $12 | $61 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
554 | $97 | $378 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
479 | $47 | $189 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
332 | $15 | $56 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
306 | $1 | $6 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
260 | $1 | $3 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
195 | $21 | $79 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
180 | $54 | $206 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
176 | $60 | $239 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
146 | $16 | $59 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
112 | $125 | $637 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
110 | $7 | $69 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
101 | $49 | $178 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 99 | $137 | $562 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
86 | $15 | $56 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
80 | $42 | $170 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
78 | $3 | $11 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
74 | $118 | $453 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
67 | $24 | $89 |
| Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg | 63 | $303 | $1,210 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
49 | $5 | $20 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
49 | $10 | $42 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
45 | $68 | $277 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
45 | $2 | $7 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
39 | $1 | $7 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
36 | $4 | $15 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $137 | $474 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
24 | $25 | $156 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
18 | $28 | $156 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
54.8% high complexity
40.6% medium
4.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,339
Total received (2018-2024)
Avg $334/year across 7 years
Bottom 25% in FL for hematology
47
Companies
109
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,310 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$30 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$439
2023
$409
2022
$522
2021
$203
2020
$543
2019
$126
2018
$98
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$319
Teva Pharmaceuticals USA, Inc.
$317
Janssen Biotech, Inc.
$269
AbbVie Inc.
$99
Takeda Pharmaceuticals U.S.A., Inc.
$93
Lilly USA, LLC
$83
E.R. Squibb & Sons, L.L.C.
$73
Amgen Inc.
$68
ABBVIE INC.
$61
Deciphera Pharmaceuticals Inc.
$60
Daiichi Sankyo Inc.
$54
Gilead Sciences, Inc.
$47
Pharmacyclics LLC, An AbbVie Company
$45
Sysmex Inostics Inc
$43
Merck Sharp & Dohme LLC
$41
PFIZER INC.
$39
BeiGene USA, Inc.
$36
GlaxoSmithKline, LLC.
$34
Eisai Inc.
$33
Adaptive Biotechnologies Corporation
$31
GT Medical Technologies, Inc
$29
ImmunoGen, Inc.
$28
Lexicon Pharmaceuticals, Inc.
$27
Incyte Corporation
$27
Mirati Therapeutics, Inc.
$26
JAZZ PHARMACEUTICALS INC.
$25
EISAI INC.
$25
Pharmacyclics LLC, an AbbVie Company
$25
ARRAY BIOPHARMA INC
$20
GE HealthCare
$19
Regeneron Healthcare Solutions, Inc.
$19
TAIHO ONCOLOGY, INC.
$18
Karyopharm Therapeutics Inc.
$18
AbbVie, Inc.
$18
Taiho Oncology, Inc.
$16
G1 Therapeutics, Inc.
$16
EMD Serono, Inc.
$15
Kite Pharma, Inc.
$15
Genentech USA, Inc.
$14
Astellas Pharma US Inc
$14
GENZYME CORPORATION
$14
Agios Pharmaceuticals, Inc.
$13
Boston Scientific Corporation
$12
ADC Therapeutics America, Inc.
$12
Heron Therapeutics, Inc.
$11
Shire North American Group Inc
$11
Secura Bio, Inc.
$9
Top 3 companies account for 38.7% of total payments
Associated products mentioned in payments ›
ALIMTA · BENDEKA · BLENREP · BRUKINSA · Blincyto · CINVANTI · COSELA · CYRAMZA · Creon · DARZALEX · ELAHERE · ERLEADA · Enhertu · FRUZAQLA · Farydak · GammaTile · IMBRUVICA · JAKAFI · KEYTRUDA · KRAZATI · LIBTAYO · LONSURF · LORBRENA · Lenvima · Lonsurf · ONUREG · OPDIVO · PYRUKYND · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · SARCLISA · TECVAYLI · Trodelvy · VENCLEXTA · VONVENDI · Varithena Administration Pack · XPOVIO · XTANDI · Xermelo · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $1 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
22
Per 100K population
4.9
County median income
$80,633
Nearest hospital
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Buck is a mixed practice specialist, with above-average Medicare volume (top 21% in FL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Buck experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Buck performed 94,350 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Buck receive payments from pharmaceutical companies?
Yes. Dr. Buck received a total of $2,339 from 47 companies across 109 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Buck's costs compare to other hematologists in Sarasota?
Dr. Buck's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Buck) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Sarasota
Browse hematologists in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology